Preparation and use of tetrahydropyrrolo [3, 2-c] pyridin-4-one derivatives for treatment of obesity, psychiatric and neurological disorders

Details for Australian Patent Application No. 2006298530 (hide)

Owner AstraZeneca AB

Inventors Cheng, Leifeng

Agent Davies Collison Cave

Pub. Number AU-B-2006298530

PCT Pub. Number WO2007/039740

Priority 60/724,156 06.10.05 US

Filing date 5 October 2006

Wipo publication date 12 April 2007

Acceptance publication date 29 October 2009

International Classifications

A61K 31/437 (2006.01)

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

C07D 471/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

Event Publications

10 April 2008 PCT application entered the National Phase

  PCT publication WO2007/039740 Priority application(s): WO2007/039740

29 October 2009 Application Accepted

  Published as AU-B-2006298530

25 February 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006298531-Biphenyloxyacetic acid derivatives for the treatment of respiratory disease

2006298529-Glazing panel handling tool